Editorial Board
Tamar Tadmor
Bnai Zion Medical Center
Editorial leadership for Journal of Advances in Leukemia
Research interests
- Chronic Lymphocytic Leukemia
- Hairy Cell Leukemia
Biography
Academic Degrees:
- 1994 MD, Faculty of Medicine, Milan, Italy
Academic Appointments:
- 2014 Clinical Assistant Professor, Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel
Professional Experience:
- 2016 to present - Head, Hematology Division and Blood Bank, Bnai Zion Medical Center, Haifa, Israel.
Selected publications
- Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccination 2022 cited 107×
- COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study 2021 cited 73×
- Real‐world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: A multicentre retrospective study 2022 cited 41×
- Severe pneumonia associated with ibrutinib monotherapy for CLL and lymphoma 2017 cited 29×
- Richter Transformation in Chronic Lymphocytic Leukemia: Update in the Era of Novel Agents 2021 cited 27×
- Daratumumab for relapsed AL amyloidosis—When cumulative real‐world data precedes clinical trials: A multisite study and systematic literature review 2020 cited 22×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JAL for your work?
This journal is guided by Tamar Tadmor (Bnai Zion Medical Center) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.